The short version
14 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Oxaliplatin
Oxaliplatin · OXALIPLATIN 200 mg/40mL · Injection, Solution · Intravenous · Qilu Pharmaceutical Co., Ltd.
NDC 67184-0510-01 · 1 VIAL, SINGLE-USE in 1 CARTON / 40 mL in 1 VIAL, SINGLE-USE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- analysis · manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $287.33 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA204368
- TE code
- AP
- Approval date
- Jun 7, 2016
- Patents / exclusivity
- None on file
Shortage history
- Planned discontinuation — Oxaliplatin, Injection, 5 mg/1 mL (NDC 25021-233-10)Jun 29, 2026
- Planned discontinuation — Oxaliplatin, Injection, 5 mg/1 mL (NDC 25021-233-20)Jun 29, 2026
- Planned discontinuation — Oxaliplatin, Injection, 5 mg/1 mL (NDC 0781-3315-70)Oct 20, 2025
- Planned discontinuation — Oxaliplatin, Injection, 5 mg/1 mL (NDC 0781-3317-80)Oct 20, 2025
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Oxaliplatin (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Apotex Corp. | OXALIPLATIN 5 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Fosun Pharma Usa Inc. | OXALIPLATIN 5 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Meitheal Pharmaceuticals Inc. | OXALIPLATIN 5 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Northstar Rx LLC | OXALIPLATIN 5 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Sandoz Inc | OXALIPLATIN 5 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Shandong New Time Pharmaceutical Co., Ltd. | OXALIPLATIN 5 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| BluePoint Laboratories | OXALIPLATIN 5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Qilu Pharmaceutical Co., Ltd. | OXALIPLATIN 100 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| Qilu Pharmaceutical Co., Ltd. | OXALIPLATIN 200 mg/40mL | Jul 15, 2026 | Sep 2, 2026 |
| Qilu Pharmaceutical Co., Ltd. | OXALIPLATIN 50 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | OXALIPLATIN 5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Baxter Healthcare Corporation | OXALIPLATIN 5 mg/mL | Jul 15, 2026 | Aug 31, 2026 |
| Eugia US LLC | OXALIPLATIN 5 mg/mL | Jul 15, 2026 | Aug 31, 2026 |
| Gland Pharma Limited | OXALIPLATIN 5 mg/mL | Jul 15, 2026 | Aug 28, 2026 |
| Mylan Institutional LLC | OXALIPLATIN 5 mg/mL | Jul 15, 2026 | Aug 28, 2026 |
| NorthStar Rx LLC | OXALIPLATIN 5 mg/mL | Jul 15, 2026 | Aug 28, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Oxaliplatin — NDC 67184-0510-01," retrieved September 3, 2026, https://drugdashboards.com/drug/67184051001.
Free to cite with attribution — see how the data is put together.